Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

Abstract:
Altogen Biosystems
(http://www.altogen.com) announced launch of new contract research
services. Located in Las Vegas, NV, Altogen Custom Services focus on
providing specialized biotechnology and pharmaceutical services, including
RNA Interference (RNAi) services, generation of stably-expressing cell
lines, assay development, screening and transfection services. In
particular, the company will draw upon their unique experience with over
hundred cancer cell lines and expertise in polymer and nanoparticle-based
gene delivery technologies.

Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

LAS VEGAS, NV | Posted on March 12th, 2008

Generation of stably-expressing cancer cell lines and primary cells can
be very expensive and time-consuming. Utilizing this method, investigators
are able to develop cells that permanently express specific genes through
their incorporation in the cellular genome. Altogen Custom Services offers
generation of stable cell lines by transforming the cell line of choice to
stably express vector or gene of interest. Optional cloning and shRNA
expression services are available. The service turnaround time is typically
3-4 weeks.

Altogen laboratory research services
(www.altogen.com/support.htm) include:

-- Transfection services (transient and stable)
-- Assay development and library screening
-- Cloning and plasmid vector construction
-- Generation of stable cell lines
-- RNAi experiments (siRNA design, synthesis, validation)
-- Gene targeting (mRNA knockdown, shRNA overexpression)
-- Custom services

####

About Altogen Biosystems
Altogen Biosystems is a life sciences company dedicated to the
development, marketing and manufacture of In Vivo and In Vitro transfection
reagents for intracellular and tissue-targeted delivery of biomolecules.
Altogen Custom Services is a laboratory contract research organization. It
provides specialized contract research to pharmaceutical, biotechnology,
and other life science organizations worldwide.

For more information, please click here

Contacts:
Altogen Biosystems
848 Rainbow Blvd #823
Las Vegas, NV 89107 USA
Tel/Fax: 1-702-989-0841

Customer Support:
1-800-658-7009
Fax: (702) 989-0841

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

A nano-roundabout for light December 10th, 2016

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project